Tuberculosis remains a major health challenge in South Africa, but professional nurse Nhlanhla Mofokeng is determined to ...

Linezolid was introduced by the World Health Organization (WHO) in 2022, as part of the BPaLM regimen, also comprising ...

In 2023, tuberculosis claimed approximately 1·3 million lives,1 providing a stark reminder of the persistent inequities and ...

The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

Physicians who champion immunization sustain herd immunity, reducing the incidence of severe diseases, hospitalizations, and ...

DOH Usec. Abdullah B. Dumama Jr, Cluster Lead of the National UHC Health Services Cluster (UHC-HSC) and concurrent head of ...

Current treatment for bedaquiline-resistant tuberculosis is linked with poor microbiological responses, unfavorable clinical ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

Tamil Nadu integrates predictive model to reduce TB deaths, prioritizing severely ill patients for prompt hospital admission.

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...

The UNAIDS annual report warns that Trump-era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...